Imiquimod treatment significantly suppressed IAV-induced peri-bronchiolar inflammation and inflammatory cell infiltration, with a strong trend for reduction in alveolitis.
← all excerpts
Intranasal and epicutaneous administration of Toll-like receptor 7 (TLR7) agonists provides protection against influenza A virus-induced morbidity in mice.
1
—
—